CASE REPORT |
|
Year : 2020 | Volume
: 9
| Issue : 6 | Page : 3157-3159 |
|
Ofloxacin-ornidazole fixed-dose combination medication-induced pancreatitis with positive rechallenge
Nikhil Bush1, Vishal Sharma1, K Chandrahasan2, Amol N Patil2
1 Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India 2 Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
Correspondence Address:
Dr, Amol N Patil Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh - 160012 India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jfmpc.jfmpc_531_20
|
|
Although ofloxacin-ornidazole fixed-dose combination (FDC) is a rampantly used antibiotic combination for mixed-infection diarrhea in India, the adverse drug reaction (ADR) associated with these FDCs remains underreported. Herein, the authors present a case report of a definitive ofloxacin-ornidazole FDC-induced pancreatitis. The nonalcoholic adult male patient showed a sharp piercing epigastric pain flowing to the back, gradually rising in severity, which started after taking ofloxacin-ornidazole FDC tablet over the counter. Serum lipase concentration measured in the emergency room was 635 units per liter (normal range- 13–60 units/L) and serum amylase was 377 units/L (normal range- 30–110 units/L). Ultrasonography and an axial computed tomography of the abdomen confirmed the diagnosis of acute pancreatitis. Ofloxacin-ornidazole FDC tablet was stopped immediately. Past treatment records confirmed accidental rechallenge. In conclusion, this is a first case report of ofloxacin-ornidazole FDC-induced pancreatitis.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|